BACKGROUND: @entity1118 is a common consequence of @entity1566 ( @entity1566 ). No therapeutic drugs or drug groups are proven to be superior for @entity9 and treatments only aim to convert @entity158 from dull to tolerable levels and not to remove it. OBJECTIVE: This study was planned to compare the effect of @entity227 ( @entity227 ) and Transcutaneous electrical nerve stimulation (TENS) on @entity158 intensity, @entity158 quality and functional capacity in @entity1566 @entity1 with @entity9 . METHODS: Twenty-four @entity1 were included and randomly categorized into two groups. In the first group (n=12), @entity227 was applied for first two weeks, 1 week wash out period and then TENS was applied for 2 weeks. In second group (n=12), TENS was applied firstly, 1 week wash out and then @entity227 were applied. @entity158 severity, @entity158 quality, and functional capacity were assessed with the visual analog scale (VAS), the @entity9 ( @entity9 ), and the Brief @entity158 Inventory (BPI), respectively. A pre-post-treatment and cross over design was used. RESULTS: Wilcoxon signed-rank tests were used for within group analyses. Mann-Whitney U tests were used for analyses that compared different groups. It was observed that @entity158 intensity decrease immediately after both applications ( @entity227 : p=0.07, TENS: p=0.08). After TENS application for 2 weeks, it was observed that significant decrease in most (p=0.04) and less (p=0.02) @entity158 intensity; while there was no significant decrease in @entity158 intensity after 2 weeks for @entity227 (p> 0.05). When findings of @entity9 were analyzed, hot (p=0.047), sharp (p=0.02), unpleasant (p= 0.03) and deep items (p=0.047) decreased after @entity227 application. When the results of BPI were detected, they were observed that the negative effect of @entity158 on moving ability (p=0.04) after @entity227 application and the negative effect of @entity158 on mood (p=0.03), relationships with others (p=0.04) and sleep (p=0.04) after TENS application decreased significantly.CONCLUSION: TENS and @entity227 therapies can be successfully used in clinical practice as an alternative treatment or as a supportive method separetely or together.

Effects of @entity227 and transcutaneous electrical nerve stimulation on @entity9 in XXXX with @entity1566 : A randomised controlled cross-over trial.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity227 :: ('MESH:D014786', 'Disease') :: ['VI', 'visual illusion'] @entity158 :: ('MESH:D010146', 'Disease') :: ['Pain', 'pain'] @entity1566 :: ('MESH:D013119', 'Disease') :: ['spinal cord injury', 'SCI'] @entity1118 :: ('MESH:D059350', 'Disease') :: ['Chronic pain'] @entity9 :: ('MESH:D009437', 'Disease') :: ['neuropathic pain', 'neuropathic pain scale', 'NPS']
@entity1 :: (9606,Species) :: ['patients']
